DERIVES D'ACIDE BILIAIRE UTILISES COMME AGONISTES DE FXR/TGR5 ET LEURS PROCEDES D'UTILISATION

• 收藏
• 分享

专利权人:

INC.;ENANTA PHARMACEUTICALS

发明人:

WANG, GUOQIANG,OR, YAT SUN,SHEN, RUICHAO,XING, XUECHAO,LONG, JIANG,DAI, PENG,GRANGER, BRETT,HE, JING

申请号：

CA2981503

公开号：

CA2981503A1

申请日:

2016.03.30

申请国别(地区):

CA

年份:

2016

代理人:

摘要：

The present invention provides compounds represented by Formula I, or pharmaceutically acceptable salts, stereoisomers, solvates, hydrates or combination thereof, (I). The invention also provides pharmaceutical compositions comprising these compounds and methods of using this compounds for treating FXR-mediated or TGR5-mediated diseases or conditions.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/